Seegene Announces Collaboration with Microsoft to Realize ‘a World Free from All Diseases’
Press Release For immediate release Seegene Announces Collaboration with Microsoft to Realize ‘a World Free from All Diseases’ Strategic collaboration to open a new chapter in the field of molecular diagnostics that aspires to ‘a…
Seegene USA, Inc. Announces Collaboration with Microbix Biosystems Inc.
Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy Expanded Collaboration to Improve Syndromic Infectious Disease Testing IRVINE, CA, USA, December 14, 2023 /EINPresswire.com/ -- Seegene USA, Inc. (“Seegene USA”), a leading developer of multiplex…
Seegene Unveils ‘Open Innovation Program Powered by Seegene’ in Partnership with Springer Nature
Together, we can create a disease-free future Register for the webcast - A replay will be available for those who register! Click ▶ Nature Research (workcast.com) Date: Thursday, September 21, 2023 Time: 8AM PDT |…
Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.
Company expands presence and support in US market. Proprietary TOCE™ technology overcomes PCR testing limitations for high multiplex applications. IRVINE, Calif., January 5, 2023 (Newswire.com) - Seegene Technologies, Inc., a subsidiary of Seegene Inc., South Korea's…
Seegene develops PCR test to detect Monkeypox Virus
Published on: PR Newswire SEOUL, South Korea, June 28, 2022 /PRNewswire/ -- Seegene Inc. (KQ965390), South Korea's leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus. The Novaplex™ MPXV Assay, which specifically targets the monkeypox virus,…
Seegene appoints Dr. Glen Hansen as Head of Medical Affairs of U.S. subsidiary
Published on: PR Newswire Dr. Hansen to provide clinical input to the product development process; strengthen strategic partnerships with U.S. networks SEOUL, South Korea, March 17, 2022 /PRNewswire/ -- Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics company, today announced the…
Seegene appoints Richard Creager as CEO of U.S. subsidiary to bolster U.S. business
Published on: PR Newswire Dr. Creager to lead U.S. business from R&D, local production to M&A: "Thrilled to create synergy to help Seegene grow as a top global molecular diagnostics company through success in U.S." …
Seegene develops reagent detecting Covid-19 infection in 30 minutes
Published on Korea Biomedical Review Seegene, a multiplex molecular diagnostics company, said that it has developed a diagnostic reagent that can identify the Covid-19 infection in 30 minutes. Seegene's new product, Allplex SARS-CoV-2 fast MDx…
Seegene Rapidly Introduces New PCR Test that Identifies the Omicron Variant, its Stealth Version, and all VOCs in a single tube
CONTACT SEEGENE TECHNOLOGIES The new assay identifies positive COVID-19 cases and distinguishes between Alpha, Beta, Gamma, Delta, Omicron and its Stealth version. Published on: PR Newswire Seegene Inc. (KQ 096530), South Korea's leading molecular diagnostics…
Omicron Variant: Letter to our customers
To Our Valued Seegene Customer, The World Health Organization has identified the Omicron variant (B.1.1.529) as the latest strain of the SARS-CoV-2 virus to be designated as a Variant of Concern. As the first cases…
Seegene’s High Multiplex PCR Assay Capable of Detecting New Omicron Variant
Published on: PR Newswire The Allplex™ SARS-CoV-2 Master Assay can simultaneously detect the wild-type coronavirus and the Omicron variant in a single test tube Seegene will support countries in need of diagnostics to help slow…
Seegene Unveils Fully Automated Molecular Testing System at the 2021 AACC
Published on: PR Newswire Seegene unveils its first fully automated MDx system, STARlet-AIOS: All-in-One System at the 2021 AACC held in the Atlanta, GA, United States AIOS is the MDx system that integrates Seegene's liquid handler and…
Seegene Introduces New SARS-CoV-2 Variants Detection Test That Can Screen Six Virus Variants Including the Delta and Delta Plus
Published on: PR Newswire Seegene launches new multiplex PCR test capable of screening six SARS-CoV-2 variants including the Delta and Delta Plus variants attributable for a recent surge in global COVID-19 cases. The new CE-IVD…
Seegene begins exporting its latest COVID-19 variant tests around the world to help contain spread of pandemic
Published on: PR Newswire Seegene can produce 300,000 variant diagnostic test kits, capable of testing 30 million people every month SEOUL, Korea (April 12, 2021) – Seegene Inc. (KQ 096530), a biotechnology company specializing in…
Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of Its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay
Published on: BUSINESS WIRE Real-time test differentiates influenza A & B, RSV and COVID-19 SEOUL, South Korea (March 1, 2021)— Seegene Inc., (KQ096530), a biotechnology company specializing in molecular diagnostics, has submitted its Allplex™ SARS-CoV-2/FluA/FluB/RSV…
Seegene’s Latest COVID-19 Test Can Simultaneously Target 4 Genes of SARS-CoV-2 and Recognize Multiple Virus Variants
Published on: PR Newswire - Seegene’s new product filters COVID-19 and variants during primary PCR testing in 1 hr 55 min- Seegene’s proprietary high multiplex technology enables detection of 10 different targets- S. Korean firm…
Seegene’s saliva test for COVID-19 is just as effective as NPS test
Published on: PR Newswire A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen. A research team at the Department of Laboratory Medicine…
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants
Published on: PR Newswire SEEGENE LAUNCHES FIRST MULTIPLEX TEST TO IDENTIFY COVID-19 MUTANTS THE MANUFACTURER OF COVID-19 TESTS CONTINUOUSLY FOLLOWS THE SPREAD OF THE VARIANTS THE KOREAN COMPANY UNDERTAKES TO COOPERATE WITH GOVERNMENTS SEOUL ,…
Seegene introduces a High-throughput 8-plex Test for Flu A, Flu B, RSV and COVID-19 with dual internal controls
SEOUL, South Korea, Sept. 8, 2020 /PRNewswire/ -- Seegene, Inc. introduced a single tube real-time RT-PCR assay, Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay, which simultaneously detects and differentiates Flu A, Flu B, RSV A/B, and three different target genes of…
Seegene’s Allplex™ 2019-nCoV Assay receives FDA Emergency Use Authorization
Published on: 매일경제 한국경제 PR Newswire 조선일보 SEOUL, Korea, Apr 22, 2020 - Seegene, Inc. announced that U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for…
Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries
Published on: PR Newswire ABC News Seegene, Inc., the leading multiplex diagnostic assay developer, today announced that the company has exported over 10 million tests of Allplex™ 2019-nCoV Assay to over 60 countries, which accounts for…
Seegene Highlights Clinical Automated Nucleic Acid Extraction System at ASM Microbe 2019
2019 American Society for Microbiology Microbe Conference: Booth #1062 Published on: PR Newswire SEOUL, South Korea, June 21, 2019 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered in South Korea, announced that it…
Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method
Published on: PR Newswire SEOUL, South Korea, Nov. 26, 2018 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR assays, announced that multi-site clinical trials for measuring clinical performance on screening the drug resistance of Enterobacteriaceae with…
Seegene Unveils New Real-time PCR Analysis Technology, Drastically Increasing Its Multiplexing Capacity
Published on: PR Newswire SEOUL, South Korea, Sept. 19, 2018 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced its proprietary technology, "MuCT™". This is a real-time PCR based data acquiring and…
Seegene Unveils Combination Test at ECCMID 2018
Published on: PR Newswire Korea Biomedical Review SEOUL, South Korea, April 17, 2018 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, announced that it will attend the 28th European Congress of Clinical Microbiology and…
Seegene develops world’s first multiplex MDx assays with its AI system
Published on: PR Newswire THE INVESTOR SEOUL, South Korea, Jan. 3, 2018 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered in South Korea, announced today that, utilizing a newly created artificial intelligence ("AI") based assay development…
Seegene inks MOU with global automated instrumentation leader Hamilton Company
Published on: PR Newswire SEOUL, South Korea, Sept. 26, 2017 /PRNewswire/ -- Seegene, a world's leading developer of multiplex molecular technologies and assays, announced that it has signed a Memorandum of Understanding (MOU) with Hamilton Company, a global…
Seegene accelerates ‘Project 100’ by securing 30 co-development partners
Published on: scientifictechnologynews Seoul, Korea, 2017/08/31 – Seegene, the world’s leading developer of multiplex molecular technologies and assays, announced that it has recently signed collaborative contracts with 30 general hospitals and reference laboratories across 15…
Unique concept of MDx, Seegene Random Access System, announced at AACC 2017
Published on: PR Newswire SEOUL, South Korea, July 26, 2017 /PRNewswire/ -- Seegene Inc. (096530.KQ), the world's leading developer of multiplex molecular diagnostics technologies and assays, is to present its unique Seegene Random Access System (the "System") at…
Seegene enters the U.S. diagnostic market in collaboration with Thermo Fisher Scientific
Published on: PR Newswire SEOUL, South Korea, May 22, 2017 /PRNewswire/ -- Seegene Inc. (096530.KQ), the world's leading developer of multiplex molecular diagnostics technologies and assays, today announced that it has entered into a new strategic collaboration…
Seegene Unlocks the Door to the Next Level of the Real-time PCR Business
Published on: PR Newswire SYS-CON MEDIA SEOUL, South Korea, April 26, 2017 /PRNewswire/ -- Seegene Inc. (096530.KQ), the leading developer of multiplex PCR technologies, announced that it is entering into more innovative and powerful business realm…
Seegene Develops New Normalization Software Technology for Molecular Diagnosis
Published on: PR Newswire NEWS PROVIDED BY Seegene Feb 14, 2017, 08:00 ET EOUL, South Korea, Feb. 14, 2017 /PRNewswire/ -- Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies today announced that it has developed…
Seegene and Hologic Form Worldwide Collaboration to Develop High Multiplex Molecular Diagnostic Assays
Published on: PR Newswire GenomeWeb Seoul, Korea, November 4, 2016 --- Seegene Inc. (096530.KQ) today announced it has entered into a worldwide collaboration agreement with Hologic (Nasdaq: HOLX) to develop and supply high multiplex real-time PCR reagents…
Seegene to Introduce Automated Development of in silico-based Multiplex Real-time PCR Assays
Published on: PR Newswire Pressemitteilung lavanguardia 共同通信PRワイヤー (プレスリリース) HiNet 新聞社群 中华网 ThaiPR.net (ข่าวประชาสัมพันธ์) LeLézard.com foodqualitynews Customized assay design that dramatically reduces development time and cost Looking for potential local strategic partners in molecular diagnostics SEOUL, South Korea, Aug 2, 2016 - Seegene,…
Seegene to Introduce Novel Real-Time PCR Technology at ASM Microbe 2016
Published on: PR Newswire Jun 08, 2016 - Introducing a new SG oligo system which significantly saves assay development time and cost- Driving standardization of the molecular diagnostics technology with a new Universal SG Fluorescence…
Seegene Technologies to Unleash Customized Multiplex PCR Solutions and Support for U.S. Market
Published on: BUSINESS WIRE Mar 07, 2016 Newly established innovation division at Seegene Technologies will deliver customized assays of increased complexity while maintaining sensitivity, specificity, and cost-effectiveness for U.S. market Seegene Technologies, Inc., a wholly-owned…
Seegene and BD Form Worldwide Collaboration to Develop Multiplex Molecular Diagnostic Assays
Published on GenomeWeb MarketWatch RTT News Seegene and BD Form Worldwide Collaboration to Develop Multiplex Molecular Diagnostic Assays Seoul, Korea, and Baltimore, MD, September 14, 2015 --- Seegene Inc. (096530.KQ) and BD Life Sciences, a segment of…
Seegene and QIAGEN Enter into a Collaboration to Develop Multiplex Molecular Diagnostic Assay
Published on: GenomeWeb Nasdaq streetinsider Seoul, Korea, and Hilden, Germany, July 8, 2015 --- Seegene Inc. (096530.KQ), today announced that it has entered into aworldwide collaboration agreement with QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA)to develop and supply…
Seegene Establishes U.S. Subsidiary. Seegene Technologies Inc. to Drive Growth in the U.S. and Global Molecular Diagnostics Market
Published on: GenomeWeb Seegene Establishes U.S. Subsidiary Seegene Technologies Inc. to Drive Growth in the U.S. and Global Molecular Diagnostics Market CONCORD, CA and SEOUL, KOREA--(Marketwired - Apr 7, 2015) - Seegene Inc. (KOSDAQ: 096530), a…